Method for collecting functional cells in vivo with high efficiency
Biologically low invasive vessels are filled with biological factors that have the activity of mobilizing specific functional cells in the body. The vessels are indwelled in the body. After specific functional cells are mobilized into the vessels, the vessels are removed from the body to collect functional cell populations mobilized to the vessels. Alternatively, the cells are directly collected from the vessels indwelled in the body.
1. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a vessel that contains a substance of any of (a) to (c) below, completely under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the vessel implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the vessel implanted in subcutaneous adipose tissue:
(a) hyaluronic acid,
(b) an extract of a cell or tissue, and
(c) a heparin-binding fraction of a cell or tissue extract,
wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without any of (a) to (c), and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
2. The method according to claim 1 , wherein the extract of a cell or tissue is an extract of a live skin tissue or blood.
3. The method of claim 1 , in which the extract of a cell or tissue is produced by a method comprising the step of immersing a cell or tissue in a solvent.
4. The method of claim 1 , in which the heparin-binding fraction of the extract of a cell or tissue is produced by a method comprising the steps of:
(a) immersing a cell or tissue in a solvent;
(b) contacting immobilized heparin with an extract prepared in step (a); and
(c) eluting a heparin-binding fraction from the immobilized heparin.
5. The method of claim 1 , wherein the method comprises a step of removing the vessel to outside the body from under the skin in subcutaneous adipose tissue of the subject after step (I) and before step (II).
6. The method of claim 1 , wherein step (II) is a step of collecting bone-marrow-derived stem cells from the vessel, which is still under the skin in subcutaneous adipose tissue of the subject.
7. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a portion of a vessel in which the portion contains a substance of any of (a) to (c) below, under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the portion implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the portion implanted in subcutaneous adipose tissue:
(a) hyaluronic acid,
(b) an extract of a cell or tissue, and
(c) a heparin-binding fraction of a cell or tissue extract,
wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without any of (a) to (c), and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
8. The method according to claim 7 , wherein the extract of a cell or tissue is an extract of a live skin tissue or blood.
9. The method of claim 7 , in which the extract of a cell or tissue is produced by a method comprising the step of immersing a cell or tissue in a solvent.
10. The method of claim 7 , in which the heparin-binding fraction of the extract of a cell or tissue is produced by a method comprising the steps of:
(a) immersing a cell or tissue in a solvent;
(b) contacting immobilized heparin with an extract prepared in step (a); and
(c) eluting a heparin-binding fraction from the immobilized heparin.
11. The method of claim 7 , wherein the method comprises a step of removing the portion to outside the body from under the skin in subcutaneous adipose tissue of the subject after step (I) and before step (II).
12. The method of claim 7 , wherein step (II) is a step of collecting bone-marrow-derived stem cells from the vessel, the portion of which is still under the skin in subcutaneous adipose tissue of the subject.
13. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a vessel that contains a substance selected from hyaluronic acid and a heparin-binding fraction of a cell or tissue extract, completely under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the vessel implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the vessel implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without the substance, and wherein the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
14. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a portion of a vessel in which the portion contains a substance selected from hyaluronic acid and a heparin-binding fraction of a cell or tissue extract, under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the portion implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the portion implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without the substance, and wherein the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
15. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a vessel that contains a substance selected from hyaluronic acid and a heparin-binding fraction of a cell or tissue extract, completely under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the vessel implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the vessel implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without the substance, and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
16. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a portion of a vessel in which the portion contains a substance selected from hyaluronic acid and a heparin-binding fraction of a cell or tissue extract, under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the portion implanted in subcutaneous adipose tissue, wherein, as a result of the presence of the substance, stem cells present in bone marrow of the subject enter the portion implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without the substance, and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
17. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a vessel that contains hyaluronic acid, completely under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the vessel implanted in subcutaneous adipose tissue, wherein, as a result of the presence of hyaluronic acid, stem cells present in bone marrow of the subject enter the vessel implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without hyaluronic acid, and wherein the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
18. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a portion of a vessel in which the portion contains hyaluronic acid, under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the portion implanted in subcutaneous adipose tissue, wherein, as a result of the presence of hyaluronic acid, stem cells present in bone marrow of the subject enter the portion implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without hyaluronic acid, and wherein the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
19. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(I) implanting for at least 12 hours a vessel that contains hyaluronic acid, completely under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the vessel implanted in subcutaneous adipose tissue, wherein, as a result of the presence of hyaluronic acid, stem cells present in bone marrow of the subject enter the vessel implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without hyaluronic acid, and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.
20. A method for collecting bone-marrow-derived stem cells from a subject, wherein the method comprises:
(1) implanting for at least 12 hours a portion of a vessel in which the portion contains hyaluronic acid, under the skin in subcutaneous adipose tissue of the subject to induce stem cells present in the bone marrow of the subject to migrate into the portion implanted in subcutaneous adipose tissue, wherein, as a result of the presence of hyaluronic acid, stem cells present in bone marrow of the subject enter the portion implanted in subcutaneous adipose tissue, wherein the vessel is made from a material that is biologically hypoallergenic when implanted into the subject without hyaluronic acid, and wherein the vessel has no openings other than at one end, and the vessel has one closed end to form an area therein to collect the bone-marrow-derived stem cells; and
(II) collecting bone-marrow-derived stem cells from the vessel.